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Invited Commentary for ‘‘From Innumeracy to Insight: The Uncertainty
of Help versus Harm in Treatment of Asymptomatic Aortic
Aneurysms’’ by Legemate and Bossuyt
M. Bjo¨rck* and A. Wanhainen
Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, SwedenIn the current issue of European Journal of Vascular and
Endovascular Surgery, Legemate and Bossuyt claim
there is insufficient evidence to support elective re-
pair of asymptomatic AAA 5.5e6.5 cm. Introducing
a model is intellectually stimulating and forces to an-
alytical thinking. Based on the outcome of their model
they conclude that patients may ‘‘expect little on lon-
gevity while they are at risk of dying from surgery or
suffering from serious morbidity’’. Consequently, they
propose a randomised controlled trial (RCT) to be car-
ried out. Furthermore, they suggest that it is innumer-
acy, inability to think in numbers, that explains why
many surgeons consider that they are offering benefit
to their patients by operating them. Although it is im-
portant to challenge established concepts and current
practice, these are rather provocative statements, and
we are grateful for having this opportunity to com-
ment on the paper.
To analyse theuncertainty of helpversusharmdue to
treatment of aneurysms, the authors created natural fre-
quency trees based on assumptions. A model address-
ing this issue would, however, need to be far more
complex. It is our experience, from studying the cost-
effectiveness of different models for AAA-screening
men1 and women,2 that difference in outcome between
simple calculations and a decision analysis model may
be significant, affecting conclusions in an unexpected
way. A decisional analysis model, such as a Markov
model, allows long time periods to be modelled, in
which risk and events are continuous. This is
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uncertain, which is the case of a rupture of an AAA.
Due to the simplicity of the model in the paper by
Legemate and Bossuyt, several important variables
were not included. For instance, no attempts were
made to evaluate the risk of rupture nor the risk of
surgery for symptoms or expansion in the surveil-
lance group, nor to extract data on major complication-
rates from the literature. One of the main criticisms
against the well performed RCTs, comparing watch-
ful waiting with early surgery among patients with
small AAAs (4e5.5 cm), was the fact that a large pro-
portion of the patients in the conservative group
were operated on.3,4 In the UK Small Aneurysm Trial
(UKSAT) 321 of the 527 (61%) randomised to ultraso-
nographic surveillance had undergone surgery, after
a mean follow-up of 4.6 years.3 In the elective sur-
gery group 517 of 563 (92%) underwent elective sur-
gery. Outcome was measured by intention to treat,
thus comparing patients operating on in 61% or
92%, respectively. After 6.5 years 74% versus 93%
had been operated on, and long-term all cause mor-
tality was better in the early surgery group, 48% vs
43%, p¼ 0.03.5 The proportion of patients being oper-
ated on is likely to be even higher among patients
with AAAs >5.5 cm.
Another important factor not contemplated by
Legemate and Bossuyt is that of life expectancy (LE).
To restrict the analysis to 5-years survival exaggerates
the impact of the perioperative mortality and morbid-
ity, and introduces a bias against surgery. Long-term
survival and life-years gained (LYG), that can be
negative when lost, are more appropriate outcome
measures, preferably using quality-adjusted life-years
(QALY). Calculating LYG and QALY balance the
625Invited Commentarynegative impact of perioperative mortality, especially
when young patients with long LE die during this
prophylactic operation, against the benefit of decreas-
ing long-term mortality.
LE in Europe is dynamic. Among Swedish men 65
year old, LE increased from 14.65 1983 to 18.49 years
in 2004. An increase of LE of 3.84 years during 22
years means a gain in LE of 64 days/year. Thus, the
65 year old man reduces his LE with less than 10
months when he becomes 66, and 65 year old women
can be expected to become 86. Although survival of
patients with AAA is somewhat decreased (z0.9),
they too benefit from this development. The specific
LE of patients with AAAs, depending on their gender
and age, is not sufficiently studied.
A factor of great importance when evaluating the
possible benefit of AAA-surgery is the autopsy-rate.
We know that with a low autopsy-rate many patients
dying from ruptured AAAwill be misclassified as car-
diac events. In 2003 only 14% of those who died in
Sweden were examined post-mortem, and only 6%
in women above 75 years.6 Any RCT comparing sur-
gery with watchful waiting must include post-
mortem examination in a majority of patients, and
certainly in the cases where premortal diagnosis is un-
clear. This issue has not been sufficiently addressed in
previous trials.
The natural course of AAA is difficult to study.
Information obtained from studies of patients with
small AAAs or patients unfit for surgery provide
incomplete information, due to differences in the
studied populations. In a large cohort of carefully
monitored patients from the UKSATand an associated
study, the rupture risk increased sharply for AAAs
>5.9 cm.7 In a study of 198 AAAs >5.5 cm in patients
refusing or unfit for elective repair, the annual rupture
risk was 10% for AAAs 5.5e6.9 cm and 32% for AAAs
>7 cm.8 In another follow-up study of patients with
untreated AAAs >5 cm, the cumulative risk of rup-
ture was 13% at one and 24% at two years.9 In the
classical study by Darling, 50% of all ruptured
AAAs found at autopsy were less than 7 cm,10 but
the diameter of AAAs are difficult to estimate at au-
topsy. Of all ruptured AAAs in the Huntingdon dis-
trict, 7.4% were less than 6 cm.11 The expansion and
change in rupture risk over time affect the results sub-
stantially, emphasizing the importance of including
these factors in a model.
No attempt was done to extract data from the liter-
ature in a systematic way. In fact, the assumptions
made seem so biased that they only serve to prove
the authors hypothesis that surgical treatment is un-
likely to have a major effect on survival in patients
with AAA. The authors consider 5% mortality and10% major complication rates associated with asymp-
tomatic AAA surgery. Many centers report mortality-
rates <3% after elective surgery. In Sweden 690
elective AAA repairs were performed during 2005
with a mortality of 2.8%, 266 (39%) were EVAR,12
With the observed low morbidity- and mortality rates
achieved by endovascular AAA repair, the assump-
tions included in the paper are even less realistic
and applicable. We do agree with the authors, of
course, that patients should be treated in hospitals
with very low surgical mortality and major morbidity
rates.
The gender aspect is completely missing in the
paper by Legemate and Bossuyt. We know from the
UKSAT that women in the surveillance group had
a three-fold rupture-risk.3 In the Swedish cause of
death registry 30% dying from ruptured AAA are
women,7 but only 15% of those operated on for
AAA in Sweden are women,12 indicating a too low
operative activity on women with AAA. Would it
really be ethically possible to randomise women to
watchful waiting with an AAA above 5.5 cm, when
this increased rupture-risk has already been shown?
Surgical decision-making in asymptomatic cases is
complex. Three key variables have to be considered:
elective operative risk, the risk of AAA rupture and
life expectancy. In selected cases an AAA diameter of
5e5.5 cm generally justifies elective repair. However,
an individual approach is recommended. For older
patients and patients with important co-morbidities,
the threshold diameter is greater, and up till 25% of
the patients are considered unfit for surgery.13,14
The crucial issue when contemplating a RCT is that
of equipoise. Given the patient has an AAA of 5.5e
6.5 cm, how many vascular surgeons would accept
themselves, or would be prepared to council their
relatives, to be randomised into the trial proposed
by Legemate and Bossuyt?
In conclusion, we believe there is enough data to
support that elective repair of AAA >5.5 cm is effec-
tive in reducing AAA-related death in most patients.
We consider a randomised trial unethical in the light
of current knowledge. Studies on specific surgical in-
dications on particular subgroups of patients in whom
surgical indications are controversial would be more
appropriate.
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